Cardlytics (NASDAQ:CDLX) reported Q4 EPS of ($0.29), $0.51 better than the analyst estimate of ($0.80). Revenue for the quarter came in at $82.5 million versus the consensus estimate of $83.54 million.
Cardlytics (NASDAQ:CDLX) reported Q4 EPS of ($0.29), $0.51 better than the analyst estimate of ($0.80). Revenue for the quarter came in at $82.5 million versus the consensus estimate of $83.54 million.